These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

797 related items for PubMed ID: 23545506

  • 1. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ, Gaber LW, Patel SJ, DeVos JM, Moore LW, Gaber AO.
    Transplantation; 2013 Apr 15; 95(7):949-54. PubMed ID: 23545506
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T, Vu D, Naraghi R, Campbell A, Min D.
    Clin Transpl; 2014 Apr 15; ():109-16. PubMed ID: 26281134
    [Abstract] [Full Text] [Related]

  • 3. Observations on the use of cidofovir for BK virus infection in renal transplantation.
    Kuten SA, Patel SJ, Knight RJ, Gaber LW, DeVos JM, Gaber AO.
    Transpl Infect Dis; 2014 Dec 15; 16(6):975-83. PubMed ID: 25412701
    [Abstract] [Full Text] [Related]

  • 4. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.
    Hassan S, Mittal C, Amer S, Khalid F, Patel A, Delbusto R, Samuel L, Alangaden G, Ramesh M.
    Transpl Infect Dis; 2014 Feb 15; 16(1):55-60. PubMed ID: 24283677
    [Abstract] [Full Text] [Related]

  • 5. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC, Bodson-Clermont P, St-Louis G, Pâquet MR, Girardin C, Fortin MC, Cardinal H, Hébert MJ, Lévesque R, Renoult E.
    Transpl Infect Dis; 2017 Jun 15; 19(3):. PubMed ID: 28207975
    [Abstract] [Full Text] [Related]

  • 6. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M, Parajuli S, Muth B, Astor BC, Panzer SE, Mandelbrot D, Zhong W, Djamali A.
    Transpl Infect Dis; 2016 Jun 15; 18(3):361-71. PubMed ID: 26998753
    [Abstract] [Full Text] [Related]

  • 7. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
    Schwarz A, Linnenweber-Held S, Heim A, Framke T, Haller H, Schmitt C.
    Transplantation; 2016 Apr 15; 100(4):844-53. PubMed ID: 26720302
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
    Westphal SG, Lyden ER, Langewisch ED, Miles CD.
    Clin Transplant; 2017 Aug 15; 31(8):. PubMed ID: 28509373
    [Abstract] [Full Text] [Related]

  • 10. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
    Alméras C, Vetromile F, Garrigue V, Szwarc I, Foulongne V, Mourad G.
    Transpl Infect Dis; 2011 Apr 15; 13(2):101-8. PubMed ID: 21371220
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
    Ji J, Feng S, Jiang Y, Wang W, Zhang X.
    Exp Clin Transplant; 2019 Dec 15; 17(6):727-731. PubMed ID: 30995893
    [Abstract] [Full Text] [Related]

  • 12. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.
    Soleymanian T, Rasulzadegan MH, Sotoodeh M, Ganji MR, Naderi G, Amin M, Saddadi F, Hakemi M, Najafi I.
    Exp Clin Transplant; 2010 Dec 15; 8(4):297-302. PubMed ID: 21143095
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA, Al-Otaibi T, Gheith O, Mosaad A, Zakaria Z, Said T, Nair P, Nampoory NM.
    Exp Clin Transplant; 2016 Feb 15; 14(1):58-65. PubMed ID: 26862825
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy.
    Chung BH, Hong YA, Kim HG, Sun IO, Choi SR, Park HS, Lee SH, Choi BS, Park CW, Choi YJ, Kim YS, Yang CW.
    Transpl Int; 2012 Jun 15; 25(6):687-95. PubMed ID: 22509924
    [Abstract] [Full Text] [Related]

  • 17. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
    Huang G, Wang CX, Zhang L, Fei JG, Deng SX, Qiu J, Li J, Chen GD, Fu Q, Chen LZ.
    Diagn Microbiol Infect Dis; 2015 Jan 15; 81(1):21-6. PubMed ID: 25445121
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prospective monitoring of BK virus replication in renal transplant recipients.
    Koukoulaki M, Grispou E, Pistolas D, Balaska K, Apostolou T, Anagnostopoulou M, Tseleni-Kotsovili A, Hadjiconstantinou V, Paniara O, Saroglou G, Legakis N, Drakopoulos S.
    Transpl Infect Dis; 2009 Feb 15; 11(1):1-10. PubMed ID: 18811631
    [Abstract] [Full Text] [Related]

  • 20. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.
    Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH.
    N Engl J Med; 2000 May 04; 342(18):1309-15. PubMed ID: 10793163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.